|Table of Contents|

The interactions of autophagy and some tumor influencing factors

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2017 01
Page:
158-160
Research Field:
Publishing date:

Info

Title:
The interactions of autophagy and some tumor influencing factors
Author(s):
Fang Biaobiao1Zhang Shujun2Cheng Binglin1
1.The First Clinical Hospital Affiliated to Harbin Medical University,Heilongjiang Harbin 150001,China;2.The Fourth Clinical Hospital Affiliated to Harbin Medical University,Heilongjiang Harbin 150001,China.
Keywords:
autophagytumoranoikisVEGFimmune response
PACS:
R730.23
DOI:
10.3969/j.issn.1672-4992.2017.01.043
Abstract:
Autophagy is a conserved cellular components degradation process which depends on autophagy-lysosome pathway in eucaryotes,and has a dramatic influence on oncogenesis,tumor development and prognosis.Autophagy also interacts with some tumor influencing factors,such as anoikis mechanism,vascular endothelial growth factor and immune response,affecting the ability of anti-radiotherapy and anti-chemotherapy,distant metastasis and dissemination,angiogenesis,nutrition supply and immunity of tumor.The interactions of autophagy and some tuomr influencing facotors may provide a synthetic therapy for tumor treatment at present.The purpose of this review is to introduce the interactions of autophagy and some tumor influencing factors.

References:

[1]White E.The role for autophagy in cancer[J].J Clin Invest,2015,125(1):42-46.
[2]Satoru Kobayashi.The newly revealed process of autophagy[J].Biol Pharm Bull,2015,38(8):1098-1103.
[3]Mu H,Liu Q,Niu H,et al.Autophagy promotes DNA-protein crosslink clearance[J].Mutat Res Genet Toxicol Environ Mutagen,2016,797:21-25.
[4]Liotta LA,Kohn E.Anoikis:cancer and the homeless cell[J].Nature,2004,430(7003):973-976.
[5]Frisch SM,Screaton RA.Anoikis mechanisms[J].Curr Opin Cell Biol,2001,13(5):555-562.
[6]Aguirre-Ghiso JA.Models,mechanisms and clinical evidence for cancer dormancy[J].Nat Rev Cancer,2007,7(11):834-846.
[7]Páez D,Labonte MJ,Bohanes P,et al.Cancer dormancy:a model of early dissemination and late cancer recurrence[J].Clin Cancer Res,2012,18(3):645-653.
[8]Sosa MS,Bragado P,Debnath J,et al.Regulation of tumor cell dormancy by tissue microenvironments and autophagy[J].Adv Exp Med Biol,2013,734:73-89.
[9]Yin X,Di W.Autophagy regulation in anoikis resistance for ovarian cancer[J].Chin J Prac Gynecol Obstetrics,2014,30(1):46-50.
[10]Fung C,Lock R,Gao S,et al.Induction of autophagy during extracellular matrix detachment promotes cell survival[J].Mol Biol Cell,2008,19(3):797-806.
[11]Wei JL,Li YC,Ma ZL,et al.miR-181a-5p promotes anoikis by suppressing autophagy during detachment induction in the mammary epithelial cell line MCF10A[J].Protein Cell,2016,7(4):305-313.
[12]Peng YF,Shi YH,Ding ZB,et,al.Autophagy inhibition suppresses pulmonary metastasis of HCC in mice via impairing anoikis resistance and colonization of HCC cells[J].Autophagy,2013,9(12):2056-2068.
[13]Avivar-Valderas A,Bobrovnikova-Marjon E,Alan Diehl J,et al.Regulation of autophagy during ECM detachment is linked to a selective inhibition of mTORC1 by PERK[J].Oncogene,2013,32(41):4932-4940.
[14]Dunn GP,Bruce AT,Ikeda H,et al.Cancer immunoediting:from immunosurveillance to tumor escape[J].Nat Immunol,2002,3(11):991-998.
[15]Schreiber RD,Old LJ,Smyth MJ,et al.Cancer immunoediting:integrating immunity's roles in cancer suppression and promotion[J].Science,2011,331(6024):1565-1570.
[16]Pan H,Chen L,Xu Y,et al.Autophagy-associated immune responses and cancer immunotherapy[J].Oncotarget,2016,7(16):21235-21246.
[17]Kroemer G,Galluzzi L,Kepp O,et al.Immunogenic cell death in cancer therapy[J].Annu Rev Immunol,2013,31:51-72.
[18]Michaud M,Martins I,Sukkurwala AQ,et al.Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice[J].Science,2011,334(6062):1573-1579.
[19]Noman MZ,Janji B,Kaminska B,et al.Blocking hypoxia-induced autophagy in tumors restores cytotoxic T-cell activity and promotes regression[J].Cancer Res,2011,71(18):5976-5986.
[20]Tittarelli A,Janji B,Van Moer K,et al.The selective degradation of synaptic connexin 43 protein by hypoxia-induced autophagy impairs natural killer cell-mediated tumor cell killing[J].J Biol Chem,2015,290(39):23670-23678.
[21]Bommarito D,Martin A,Forcade E,et al.Enhancement of tumor cell susceptibility to natural killer cell activity through inhibition of the PI3K signaling pathway[J].Cancer Immunol Immunother,2016,65(3):355-366.
[22]Lévy J,Cacheux W,Bara MA,et al.Intestinal inhibition of Atg7 prevents tumour initiation through a microbiome-influenced immune response and suppresses tumour growth[J].Nat Cell Biol,2015,17(8):1062-1073.
[23]Ferrara N,Gerber HP,LeCouter J,et al.The biology of VEGF and its receptors[J].Nat Med,2003,9(6):669-676.
[24]Sia D,Alsinet C,Newell P,et al.VEGF signaling in cancer treatment[J].Curr Pharm Des,2014,20(17):2834-2842.
[25]Stanton MJ,Dutta S,Zhang H,et al.Autophagy control by the VEGF-C/NRP-2 axis in cancer and its implication for treatment resistance[J].Cancer Res,2013,73(1):160-171.
[26]Wang H,Wang Y,Li D,et al.VEGF inhibits the inflammation in spinal cord injury through activation of autophagy[J].Biochem Biophys Res Commun,2015,464(2):453-460.

Memo

Memo:
-
Last Update: 2016-12-01